Wednesday, 22nd June Advances in Neuroblastoma Research Congress 2016

• Emerging epigenetic targets in MYCN-amplified neuroblastoma - Kimberly Stegmaier

• Neuroblastoma is bi-phasic and includes classical neuro-epithelial cells and chemo-resistant mesenchymal cells - Rogier Versteeg
• Distal chromosome 6q-deletion defines a subgroup of ultra-high risk neuroblastoma patients - Pauline Depuydt
• Chemical proteomics defines kinome responses to ALK inhibition in neuroblastoma - Yael P Mosse
• Enhancing efficacy of immune checkpoint blockade with anti-macrophage targeted therapy - Shahab Asgharzadeh

• Altering the MYCN/MAX ratio in a drosophila MYCN model leads to homeotic transformation of the eye to wing through deregulation of specific HOX genes - Giovanni Perini
• Identification and reprogramming of mesenchymal-type cells in neuroblastoma - Johan van Nes
• Induction of a metabolic switch in neuroblastoma and in other human cancer types upon targeting MYC - Marie Arsenian-Henriksson
• The histone methyltransferase DOT1L induces neuroblastoma progression by regulating gene transcription - Tao Liu
• Frequency of high and low level clonal ALK mutations in high risk neuroblastoma patients. A SIOPEN study. - Angela Bellini

• I-131-meta-iodobenzylguanidine therapy improves survival in high-risk neuroblastoma patients with mIBG positive residual metastatic disease - Thorsten Simon
• Did we improve results in infants with MYCN Amplified Neuroblastoma? Comparison of treatment strategy and outcomes in INES 99.4 and HR-NBL1/ SIOPEN. A SIOPEN Study   - Adela Cañete
• Myeloablative busulfan/melphalan (BuMel) consolidation following induction chemotherapy for patients with high-risk neuroblastoma. A Children’s Oncology Group (COG) study. - Meaghan Granger
• DFMO maintains remission and increases overall survival in high risk neuroblastoma: results of a phase II prevention trial - Giselle Sholler
• The benefit of myeloablative chemotherapy with autologous stem cell transplantation in high-risk neuroblastoma patients is stable during long term follow-up. Results of the NB97 trial. - Thorsten Simon

Lunch boxes can be collected in the ground floor foyer.